| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.21B | 23.04B | 22.62B | 17.63B | 33.61B | 25.78B |
| Gross Profit | 39.96B | 21.73B | 20.05B | 17.63B | 17.06B | 19.51B |
| EBITDA | 8.93B | 9.15B | 9.97B | 11.17B | 6.21B | 7.84B |
| Net Income | 6.17B | 6.33B | 6.39B | 7.29B | 3.67B | 4.78B |
Balance Sheet | ||||||
| Total Assets | 1.09T | 1.05T | 1.02T | 975.58B | 967.82B | 951.29B |
| Cash, Cash Equivalents and Short-Term Investments | 123.94B | 106.31B | 115.13B | 130.06B | 118.60B | 137.80B |
| Total Debt | 167.58B | 244.67B | 227.63B | 173.26B | 119.50B | 116.01B |
| Total Liabilities | 1.04T | 1.00T | 969.24B | 923.40B | 917.41B | 896.63B |
| Stockholders Equity | 52.29B | 49.70B | 50.31B | 51.24B | 49.91B | 53.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -191.00M | -56.15B | 4.83B | -11.34B | -15.13B |
| Operating Cash Flow | 0.00 | 160.00M | -55.82B | 5.07B | -11.11B | -14.94B |
| Investing Cash Flow | 0.00 | -69.58B | -6.03B | -1.67B | -5.31B | 6.22B |
| Financing Cash Flow | 0.00 | 55.59B | 38.65B | -4.89B | 4.65B | 5.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €15.63B | 5.57 | 11.85% | 2.07% | 2.01% | 79.48% | |
60 Neutral | €70.02B | 12.40 | 12.05% | 5.10% | 0.12% | -2.71% | |
58 Neutral | €10.14B | 10.61 | 14.36% | 5.79% | -6.64% | ― | |
57 Neutral | €24.00B | 14.95 | 9.85% | 4.36% | -12.70% | -12.34% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | €12.84B | 6.94 | 6.31% | 5.32% | 16.35% | 67.44% | |
53 Neutral | €18.21B | ― | 6.47% | 5.40% | -15.54% | 10.53% |